Tradestie Institutional Equity Comparison Engine
GENZ vs ALKS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALKS Overall Edge
ALKS Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alkermes Inc. plc (ALKS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GENZ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ALKS at 133.3x Forward P/E and 11.5% operating margin (+21.8% YoY). In options structure, GENZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALKS sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ALKS
GENZ N/M vs ALKS 133.3x Fwd P/E
Growth & Margin Winner
ALKS
Op Margin N/A vs 11.5% ยท YoY N/A vs +21.8%
Momentum & Technical Winner
ALKS
1Y +4.0% vs +50.0% ยท 52W Pos 32% vs 68%
Options & Structure Winner
ALKS
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
GENZ
US Equity
GENZ
Institutional Equity
$36.39
-2.5% 1D
Market Cap
N/A
1M Return
-3.98%
1Y Return
+4.02%
Forward P/E
N/M
Unified AI Score
44.3 / 100
HOLD
Tech 49.0
Fund 50.0
Flow 50.0
Mom 64.0
ALKS
NASDAQ
Alkermes Inc. plc
Pharmaceutical Preparations
$46.53
-1.06% 1D
Market Cap
$7.9B
1M Return
+12.88%
1Y Return
+50.05%
Forward P/E
133.3x
Unified AI Score
32.1 / 100
SELL
Tech 16.0
Fund 39.0
Flow 68.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GENZ +4.02%
ALKS +50.05%
Spread: +29.23 pp (ALKS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GENZ TTM Op. Margin: N/A
ALKS TTM Op. Margin: 11.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GENZ vs ALKS. Trailing 12-month operating profitability (GENZ N/A vs ALKS 11.5%) and valuation multiples (GENZ N/M vs ALKS 133.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GENZ | ALKS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $7.9B | Larger Scale | ALKS |
| Trailing P/E Ratio Valuation | N/M | 133.3x | Lower Multiple | ALKS |
| Forward P/E Ratio Valuation | N/M | 133.3x | Lower Multiple | ALKS |
| Revenue Growth (YoY) Growth | N/A | +21.8% | Higher Growth | ALKS |
| Operating Margin (TTM) Profitability | N/A | 11.5% | Higher Margin | ALKS |
| Net Profit Margin Profitability | N/A | -0.0% | Higher Margin | ALKS |
| Return on Equity (ROE) Capital Efficiency | N/A | -0.0% | Higher ROE | ALKS |
| 52-Week Range Position Momentum | 32% ($34โ$41) | 68% ($27โ$56) | Stronger Trend | ALKS |
| Beta / 30D Volatility Risk Regime | 0.85ฮฒ ยท 27% Vol | 0.75ฮฒ ยท 26% Vol | Lower Realized Risk | ALKS |
| Unified Institutional Score Composite Signal | 44.3 / 100 (HOLD) | 32.1 / 100 (SELL) | Higher Composite | GENZ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GENZ vs ALKS Buy Guide
GENZ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ALKS
CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GENZ nor ALKS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.